Læknablaðið - 15.01.1994, Page 34

24
LÆKNABLAÐIÐ
Chlamydia TWAR antibody. J Infect Dis 1988; 158:
1095-7.
4. Grayston JT, Campbell LA. Kuo CC, et al. A new
respiratory tract pathogen; Chlamydia pneumoniae,
strain TWAR. J Infect Dis 1990; 161: 618-25.
5. Saikku P, Wang SP, Kleemola M, Brander E,
Rusanen E, Grayston JT. An epidemic of mild
pneumonia due to an unusual strain of Chlamydia
psiltaci. J Infect Dis 1985; 151: 832-9.
6. Grayston JT, Diwan VK, Cooney M, Wang SP.
Community and hospital acquired pneumonia
associated with Chlamydia TWAR infection
demonstrated serologically. Arch Intern Med 1989;
149: 169-73.
7. Sundelöf B, Gnarpe J, Gnarpe H, Grillner L,
Darougar S. Chlamydia pneumoniae in swedish
patients. Scand J Infect Dis 1993; 25: 429-33.
8. Grayslon JT, Mordhorst CH, Bruu AL, Vene S,
Wang SP. Countrywide epidemics of Chlamydia
pneumoniae strain TWAR in Scandinavia, 1981-1983.
J Infect Dis 1989; 159: 1111-4.
9. Puolakkainen M. Ukkonen P. Saikku P. The
seroepidemiology of Chlamydiae in Finland over the
period 1971 to 1987. Epidem Inf 1989; 1102: 287-95.
10. Stolk-Engelaar MVM, Peeters MF. Heeft Chlamydia
TWAR betekenis in Nederland? Ned Tijdschr
Geneeskd 1990; 134: 1094-7.
11. Briem H, Guðmundsson S, Einarsson EÞ. Algengi
HIV smits meðal sjúklinga sem rannsakaðir voru
á Borgarspítala 1986 og 1989-1990. 9. þing Félags
íslenskra lyflækna, Vestmannaeyjum, maí 1990.
Læknablaðið 1990; 76: 461.
12. Wang SP, Kou CC, Grayston JT. Formalinized
C. trachomatis organisms as antigen in the
microimmunofluorescence test. J Clin Microbiol
1979; 10: 259-61.
13. Saikku P, Mattila K, Nieminen MS, et al. Serological
evidence of an association of a novel Clilamydia,
TWAR, with chronic coronary heart disease and acute
myocardial infarclion. Lancet 1988; ii: 983-6.
14. Smith SB, Cochrane SA. Repetti CF. Evaluation
of a fluorescence immunoassay for Toxoplasma
IgM antibodies. I: Program and Abstracts of
the 87th Annual Meeting of the American
Society of Microbiology, Atlanta, Georgia, 1987:
417.
15. Verkooyen RP, Hazenberg MA, van Haaren GH,
et al. Age related interference with Clamydia
pneumoniae microimmunofluorescence serology due
to circulating rheumatoid factor. J Clin Microbiol
1992; 30: 1287-90.
16. Jónsson Þ, Amason JA. Valdimarsson H. Enzyme-
linked immunosorbent assay (ELISA) screening test
for detection of rheumatoid factor. Rheumatology
1986; 6: 199-204.
17. Byron WB, Hollander M. Statistics; A Biomedical
Introduction. New York: John Wiley & Sons, 1977:
211-5.
18. Snedecor GW, Cochran WG. Statislical Methods.
Ames, Iowa: The Iowa State University Press, 1980:
107-35.
19. Wang J-H, Liu Y-C, Cheng D-L, Yeng M-Y, Chen
Y-S, Chen B-C. Seroprevalence of Chlamydia
pneumoniae in Taiwan. Scand J Infect Dis 1993; 25:
565-8.
20. Shirodaria PV, Fraser KB, Stanford F. Secondary
fluorescent staining of virus antigen by rheumatoid
factor and fluorescein-conjugated anti-IgM. Ann
Rheum Dis 1973; 32: 53-7.
21. Allander E, Bjömsson OJ, Kolbeinsson A, Olafsson
Ó, Sigfússon N, Þorsteinsson J. Rheumaloid factor in
Iceland: A population study. Int J Epidemiol 1972: 1:
211-23.
22. Dcqueker J, van Noyen R, Vandepitte J. Age-related
rheumatoid factors-incidence and characteristics. Ann
Rheum Dis 1969; 28: 431-5.